<DOC>
	<DOCNO>NCT01942161</DOCNO>
	<brief_summary>The objective study investigate efficacy safety three different dos aripiprazole ( 2 mg/day , 6-12 mg/day , 24-30 mg/day ) orally administer period 6 week pediatric patient ( age 13-17 year ) schizophrenia</brief_summary>
	<brief_title>A Short Treatment Study Aripiprazole Pediatric Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Patients diagnosis schizophrenia ( 295.30 , 295.10 , 295.20 , 295.90 , 295.60 ) , accord DSMⅣTR ( M.I.N.I.KID use backup ) Male female patient age 1317 year ( IC end dose ) Patients PANSS score 70 [ start dosing ( Day 1 baseline Patients , addition legal guardian , provide write informed consent , understood detail study Inpatient outpatient status Patients diagnosis disease except schizophrenia , accord DSMIVTR Patients compulsorily admit hospital Patients mental retardation Patients thyroid disorder Patients history receive treatment clozapine , receive sufficient dos two kind antipsychotic drug four week fail respond treatment Patients receive prohibited concomitant medication therapy list table 6.41 start prohibit concomitant medication timeframe [ confirm start dosing ( Day 1 ) baseline ] . Patients history receive treatment aripiprazole Patients fall contraindication list ABILIFY package insert Patients serious hepatic , renal , cardiac hematopoietic disorder Patients history complication organic brain disorder convulsive disorder epilepsy Patients diabetes . patient fall follow : fast blood glucose level ≧126 mg/ｄL , nonfasting blood glucose level ≧200 mg/dL , HbA1c≧6.5 % Patients history complication suicide attempt , suicidal think selfharm Patients score ≧2 ( mild ) PART1 evaluation CGISS Patients history complication malignant syndrome , tardive dyskinesia paralytic ileus Patients state physical exhaustion accompany condition dehydration malnutrition Patients history complication water intoxication Patients Parkinson 's disease Pregnant woman , parturient woman , nurse woman , woman childbearing potential wish become pregnant trial . However , woman childbearing potential practicing appropriate method contraception negative pregnancy test result eligible inclusion study . Patients diagnosis substancerelated disorder accord DSMⅣTR within past 3 month Patients positive drug screen ( urine ) result Study enrollment otherwise judged inappropriate Investigator Subinvestigator</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Schyzophrenia , pediatric patient</keyword>
</DOC>